Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study.

@article{Lefrre2004SequentialCR,
  title={Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study.},
  author={François Lefr{\`e}re and Alain Delmer and Vincent Levy and Richard Delarue and B. Varet and Olivier Hermine},
  journal={Haematologica},
  year={2004},
  volume={89 10},
  pages={1275-6}
}
This study is a long-term follow-up analysis evaluating clinical outcome of patients with mantle-cell lymphoma treated by the sequential CHOP and DHAP chemotherapy followed by autografting. The median overall survival of 81 months (95% CI, 66-not reached) and the median event free survival of 51 months (95% CI, 43-not reached) confirm the improvement in outcome obtained by such protocol.